weight regain tirzepatide To keep pounds off, patients may need to continue taking loss drug, study suggests Tirzepatide Demonstrates Sustained Weight Loss

AUC: area under the curve

Those with conditions like IBS, IBD, gastritis, or ulcers often use oral protocols with doses of 0.5 to 1 mg daily to maximize local gastrointestinal exposure

This isn't an exhaustive list, but it highlights the unique considerations each compound brings to the table

It is not a substitute for dose math or sterile-technique training

Late in 2023 the Food and Drug Administration approved Zepbound (tirzepatide) injection for chronic weight management in adults with obesity and a BMI of 30 or over with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity

Addressing common injection site concerns Its normal to have questions about the comfort of the injection